Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5204039
Max Phase: Preclinical
Molecular Formula: C47H74N12O13S2
Molecular Weight: 1079.31
Associated Items:
ID: ALA5204039
Max Phase: Preclinical
Molecular Formula: C47H74N12O13S2
Molecular Weight: 1079.31
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@@H]2CCCN2)CSCC(=O)CSC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC1=O
Standard InChI: InChI=1S/C47H74N12O13S2/c1-24(2)16-32-41(66)52-26(5)38(63)53-31(9-7-15-51-47(48)49)40(65)59-37(45(70)57-35(19-60)46(71)72)23-74-21-29(62)20-73-22-36(58-39(64)30-8-6-14-50-30)44(69)55-33(17-25(3)4)42(67)56-34(43(68)54-32)18-27-10-12-28(61)13-11-27/h10-13,24-26,30-37,50,60-61H,6-9,14-23H2,1-5H3,(H,52,66)(H,53,63)(H,54,68)(H,55,69)(H,56,67)(H,57,70)(H,58,64)(H,59,65)(H,71,72)(H4,48,49,51)/t26-,30-,31-,32-,33-,34-,35-,36+,37-/m0/s1
Standard InChI Key: RTKNZKHVHKEAIK-OKFTZIRFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1079.31 | Molecular Weight (Monoisotopic): 1078.4940 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Gonschorek P, Zorzi A, Maric T, Le Jeune M, Schüttel M, Montagnon M, Gómez-Ojea R, Vollmar DP, Whitfield C, Reymond L, Carle V, Verma H, Schilling O, Hovnanian A, Heinis C.. (2022) Phage Display Selected Cyclic Peptide Inhibitors of Kallikrein-Related Peptidases 5 and 7 and Their In Vivo Delivery to the Skin., 65 (14.0): [PMID:35653695] [10.1021/acs.jmedchem.2c00306] |
Source(1):